These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1645830)

  • 1. [Flumazenil, hepatic encephalopathy and benzodiazepines].
    Sacristán JA; Soto J; Francis D; Sánchez R
    Med Clin (Barc); 1991 Mar; 96(8):317. PubMed ID: 1645830
    [No Abstract]   [Full Text] [Related]  

  • 2. [Benzodiazepine antagonists in the treatment of heptic encephalopathy].
    Ferenci P; Grimm G
    Leber Magen Darm; 1989 Dec; 19(6):322-5. PubMed ID: 2575692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of flumazenil in hepatic encephalopathy.
    Grimm G; Katzenschlager R; Holzner F; Ferenci P; Schneeweiss B; Laggner A; Lenz K; Druml W; Madl C
    Eur J Anaesthesiol Suppl; 1988; 2():147-9. PubMed ID: 2842131
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical pharmacology of flumazenil--a benzodiazepine receptor antagonist].
    Janicki P; Rewerski W
    Pol Tyg Lek; 1988 Dec 19-26; 43(51-52):1653-6. PubMed ID: 2855862
    [No Abstract]   [Full Text] [Related]  

  • 5. Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial.
    Pomier-Layrargues G; Giguère JF; Lavoie J; Perney P; Gagnon S; D'Amour M; Wells J; Butterworth RF
    Hepatology; 1994 Jan; 19(1):32-7. PubMed ID: 8276366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of benzodiazepine in hepatic encephalopathy.
    Mullen KD
    Hepatology; 1995 Feb; 21(2):604-5. PubMed ID: 7843738
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current possibilities in the therapy of hepatic encephalopathy].
    Meier PJ; Bansky G
    Schweiz Med Wochenschr; 1990 Apr; 120(15):553-6. PubMed ID: 2159659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [GABA-benzodiazepine receptor complex: therapeutic role of benzodiazepine antagonists].
    Andresen M; Arrese M; Dougnac A; Godoy J; Prat G; Chianale J
    Rev Med Chil; 1989 Aug; 117(8):944-6. PubMed ID: 2562414
    [No Abstract]   [Full Text] [Related]  

  • 9. An interaction between benzodiazepines and neuroactive steroids at GABA A receptors in cultured hippocampal neurons.
    Ahboucha S; Coyne L; Hirakawa R; Butterworth RF; Halliwell RF
    Neurochem Int; 2006 Jun; 48(8):703-7. PubMed ID: 16487630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Electroencephalographic study of the effect of a benzodiazepine antagonist in hepatic encephalopathy].
    Pidoux B; Zylberberg P; Valla D; Opolon P
    Neurophysiol Clin; 1989 Dec; 19(6):469-76. PubMed ID: 2559309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzodiazepine receptor ligands and the syndrome of hepatic encephalopathy.
    Jones EA; Skolnick P
    Prog Liver Dis; 1990; 9():345-70. PubMed ID: 2156301
    [No Abstract]   [Full Text] [Related]  

  • 12. Brain GABA and benzodiazepine receptors in hepatic encephalopathy.
    Butterworth RF
    Rev Invest Clin; 1990 Jul; 42 Suppl():137-40. PubMed ID: 19256153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effect of pharmacological modulation of the GABAA-benzodiazepine receptor on hepatic encephalopathy in the rat: comparison with uremic encephalopathy.
    Steindl P; Püspök A; Druml W; Ferenci P
    Hepatology; 1991 Dec; 14(6):963-8. PubMed ID: 1660024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study.
    Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Francavilla R; Barbarini G
    Hepatology; 1998 Aug; 28(2):374-8. PubMed ID: 9695999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the therapeutic effect of flumazenil in hepatic encephalopathy using cerebral cartography].
    Bello Mimbrera G; García de León M; de la Torre Gutiérrez S; Montero Vázquez J; Torres Salcines J; de la Torre Fernández JM
    Rev Esp Enferm Apar Dig; 1989 Mar; 75(3):277-9. PubMed ID: 2499914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flumazenil: a benzodiazepine antagonist.
    Hoffman EJ; Warren EW
    Clin Pharm; 1993 Sep; 12(9):641-56; quiz 699-701. PubMed ID: 8306565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic hepatic encephalopathy treated by long-term intravenous administration of flumazenil in ambulatory care].
    Péroux JL; Paolini O; Tran A; Frappa B; Rampal P
    Gastroenterol Clin Biol; 1996 Feb; 20(1):106-8. PubMed ID: 8734316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flumazenil therapy for hepatic encephalopathy in cirrhotic patients: a double-blind pragmatic randomized, placebo study.
    Cadranel JF; el Younsi M; Pidoux B; Zylberberg P; Benhamou Y; Valla D; Opolon P
    Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):325-9. PubMed ID: 7600138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous GABAergic modulators in the pathogenesis of hepatic encephalopathy.
    Rothstein JD; Olasmaa M
    Neurochem Res; 1990 Feb; 15(2):193-7. PubMed ID: 2159124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute effect of flumazenil in refractory hepatic encephalopathy].
    Chesta J; Brahm J; Poniachik J
    Rev Med Chil; 1989 Sep; 117(9):1049-50. PubMed ID: 2519472
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.